Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHP1401 in mild-moderate Alzheimer's disease
NCT03055741Phase 2Completed
- Sponsor
- Daehwa Pharmaceutical Co., Ltd.
- Start
- Dec 2016
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of DHP1401 in Alzheimer's disease (AD), sponsored by Daehwa Pharmaceutical Co., Ltd.. Started Dec 2016; status: completed.
02
Drugs
DHP1401
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03055741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03055741.